VBI Vaccines
VBIV
#10650
Rank
A$2.71 M
Marketcap
A$0.09461
Share price
0.00%
Change (1 day)
-90.19%
Change (1 year)

Earnings for VBI Vaccines (VBIV)

Earnings in 2024 (TTM): -A$0.13 Billion

According to VBI Vaccines 's latest financial reports the company's current earnings are A$9.41 Million. In 2023 the company made an earning of -A$0.14 Billion, an increase over its 2022 earnings that were of -A$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for VBI Vaccines from 1998 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.13 Billion-6.18%
2023 -A$0.14 Billion-18.06%
2022 -A$0.17 Billion62.43%
2021 -A$0.11 Billion50.88%
2020 -A$66.98 Million-15.66%
2019 -A$79.42 Million-13.82%
2018 -A$92.15 Million61.32%
2017 -A$57.13 Million57.8%
2016 -A$36.2 Million-67.39%
2015 -A$0.12 Billion1527.36%
2014 -A$6.83 Million36.21%
2013 -A$5.01 Million-63.91%
2012 -A$13.88 Million-59.19%
2011 -A$34.01 Million227.23%
2010 -A$10.4 Million1741.53%
2009 -A$0.57 Million14.52%
2008 -A$0.5 Million-42.93%
2007 -A$0.87 Million21.8%
2006 -A$0.71 Million172.39%
2005 -A$0.27 Million115.38%
2004 -A$0.13 Million-42.27%
2003 -A$0.21 Million109.27%
2002 -A$0.11 Million17.89%
2001 -A$0.09 Million-369.64%
2000 A$0.03 M-69.24%
1999 A$0.1 M12.77%
1998 A$0.09 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-A$26.31 Million-78.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
-A$47.18 Million-60.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-A$0.61 Billion 404.31%๐Ÿ‡บ๐Ÿ‡ธ USA